TRATAMIENTO Y PRONÓSTICO DE LAS VASCULITIS ANCA + ...
TRATAMIENTO Y PRONÓSTICO DE LAS VASCULITIS ANCA + ...
TRATAMIENTO Y PRONÓSTICO DE LAS VASCULITIS ANCA + ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Tratamiento Vasculitis <strong>ANCA</strong> +<br />
Terapias Biológicas<br />
Anti-TNF: Anti TNF:<br />
Infliximab: Infliximab:<br />
3-5 3 5 mg/Kg mg Kg cada 2-8 2 8 semanas + CF + PDN en<br />
pacientes con VL refractarias<br />
Booth A et al. Prospective study of TNF-alpha blockade with infliximab in <strong>ANCA</strong>associated<br />
vasculitis. J Am Soc Nephrol 2004<br />
Kogh K et al. Induction of remisison by B lymphocyte depletion in 11 patients with<br />
refractory <strong>ANCA</strong>-associated vasculitis. Arthritis Rheum 2005
Change language